|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 19 September 2006
doi: 10.1242/jcs.03162
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |


1 Division of Bone and Mineral Diseases, Washington University School of Medicine, 660 S. Euclid Avenue, St Louis, MO 63110, USA
2 Department of Internal Medicine, Chonnam University Research Institute of Medical Sciences, Chonnam National University Medical Gwangju, Republic of Korea
3 Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo, Brasil
4 Institut für Genetik, Universität Bonn, Germany
¶ Author for correspondence (e-mail: rcivitel{at}im.wustl.edu)
Accepted 6 July 2006
Connexin43 (Cx43) is involved in bone development, but its role in adult bone homeostasis remains unknown. To overcome the postnatal lethality of Cx43 null mutation, we generated mice with selective osteoblast ablation of Cx43, obtained using a Cx43fl allele and a 2.3-kb fragment of the
1(I) collagen promoter to drive Cre in osteoblasts (ColCre). Conditionally osteoblast-deleted ColCre;Cx43/fl mice show no malformations at birth, but develop low peak bone mass and remain osteopenic with age, exhibiting reduced bone formation and defective osteoblast function. By both radiodensitometry and histology, bone mineral content increased rapidly and progressively in adult Cx43+/fl mice after subcutaneous injection of parathyroid hormone (PTH), an effect significantly attenuated in ColCre;Cx43/fl mice, with Cx43/fl exhibiting an intermediate response. Attenuation of PTH anabolic action was associated with failure to increase mineral apposition rate in response to PTH in ColCre;Cx43/fl, despite an increased osteoblast number, suggesting a functional defect in Cx43-deficient bone-forming cells. In conclusion, lack of Cx43 in osteoblasts leads to suboptimal acquisition of peak bone mass, and hinders the bone anabolic effect of PTH. Cx43 represents a potential target for modulation of bone anabolism.
Key words: Gap junctions, Connexin43, Teriparatide, Bone anabolic agents, Conditional gene deletion
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
F. Lima, C. Niger, C. Hebert, and J. P. Stains Connexin43 Potentiates Osteoblast Responsiveness to Fibroblast Growth Factor 2 via a Protein Kinase C-Delta/Runx2-dependent Mechanism Mol. Biol. Cell, June 1, 2009; 20(11): 2697 - 2708. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Siller-Jackson, S. Burra, S. Gu, X. Xia, L. F. Bonewald, E. Sprague, and J. X. Jiang Adaptation of Connexin 43-Hemichannel Prostaglandin Release to Mechanical Loading J. Biol. Chem., September 26, 2008; 283(39): 26374 - 26382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. VanKoevering and B. O. Williams Transgenic Mouse Strains for Conditional Gene Deletion During Skeletal Development IBMS BoneKEy, May 1, 2008; 5(5): 151 - 170. [Abstract] [Full Text] [PDF] |
||||